NFE2L2 and ulcer disease: The idea could extend to wound healing – imagine an AM graft engineered to overexpress Nrf2 or HO-1, providing a localized boost in anti-oxidative defense for a non-healing ulcer, or an AM seeded with cells carrying genes for vascular endothelial growth factor (VEGF) to stimulate blood vessel growth in an ischemic limb wound.